Citigroup’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.73M Buy
89,742
+44,040
+96% +$4.45M 0.01% 1566
2025
Q4
$3.64M Buy
45,702
+28,402
+164% +$1.86M ﹤0.01% 2237
2025
Q3
$808K Sell
17,300
-298,362
-95% -$11.7M ﹤0.01% 3298
2025
Q2
$11.6M Sell
315,662
-293,726
-48% -$11.3M 0.01% 1286
2025
Q1
$21.5M Buy
609,388
+340,934
+127% +$13.8M 0.02% 931
2024
Q4
$11.7M Buy
268,454
+150,516
+128% +$7.6M 0.01% 1274
2024
Q3
$5.35M Buy
117,938
+59,571
+102% +$2.59M ﹤0.01% 1786
2024
Q2
$2.27M Sell
58,367
-219,308
-79% -$8.2M ﹤0.01% 2244
2024
Q1
$8.95M Buy
277,675
+116,634
+72% +$3.46M 0.01% 1319
2023
Q4
$4.62M Buy
161,041
+63,807
+66% +$1.53M 0.01% 1645
2023
Q3
$2.69M Sell
97,234
-25,290
-21% -$750K ﹤0.01% 1799
2023
Q2
$3.28M Sell
122,524
-141,244
-54% -$3.47M ﹤0.01% 1790
2023
Q1
$5.71M Buy
263,768
+156,876
+147% +$3.86M 0.01% 1438
2022
Q4
$2.55M Sell
106,892
-138,253
-56% -$2.94M ﹤0.01% 1860
2022
Q3
$4.83M Buy
245,145
+135,598
+124% +$2.98M 0.01% 1585
2022
Q2
$2.13M Buy
109,547
+80,987
+284% +$1.58M ﹤0.01% 2055
2022
Q1
$729K Sell
28,560
-107,298
-79% -$2.34M ﹤0.01% 3225
2021
Q4
$3.42M Buy
135,858
+62,564
+85% +$1.76M ﹤0.01% 2154
2021
Q3
$2.02M Sell
73,294
-49,023
-40% -$1.43M ﹤0.01% 2547
2021
Q2
$3.88M Buy
122,317
+31,314
+34% +$1.09M ﹤0.01% 2132
2021
Q1
$4.17M Buy
91,003
+80,526
+769% +$3.61M ﹤0.01% 1911
2020
Q4
$415K Buy
10,477
+7,973
+318% +$315K ﹤0.01% 4368
2020
Q3
$87K Sell
2,504
-1,648
-40% -$45.6K ﹤0.01% 5222
2020
Q2
$131K Buy
4,152
+29
+0.7% +$912 ﹤0.01% 5347
2020
Q1
$90K Buy
+4,123
New +$114K ﹤0.01% 5430

Other funds holding RVMD